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Abstract 13 
Foot ulcers, a common complication of diabetes, can cause physical incapacity and are 14 
derived from several factors, including poor wound healing. New therapeutic strategies are 15 
needed to minimize this complication for the sake of patients’ health. We therefore developed 16 
a new chitosan- polyurethane hydrogel membrane (HPUC) and the test results confirmed 17 
that HPUC present low cytotoxicity and improved wound healing when used with 18 
mononuclear bone marrow fraction cells in the diabetic rat model. The biodegradable 19 
hydrogels were produced in block copolymer networks with a combination of chitosan blocks 20 
and biodegradable polyurethane. The membranes were characterized by FTIR, 13C-NMR 21 
and thermogravimetry. Swelling and hydrolytic degradation were also evaluated. The non-22 
solubility of the membranes in good solvents and the chemical characterization confirmed 23 
that the network structure was formed between the PU and the chitosan through 24 
urea/urethane bonds. The findings confirm that the HPUC have interesting properties that 25 
make them suitable for wound healing applications. 26 
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 28 
1. Introduction 29 
The diabetes mellitus (DM) group of metabolic diseases, whose main characteristic is their 30 
hyperglycemic status, can be caused by the lack of insulin, a deficit in the production or 31 
reception of this hormone, among other causes. This disease is associated with several 32 
complications such as nephropathies, retinopathies, cardiovascular diseases, ulcers and limb 33 
amputation. It is a major public health problem worldwide due to its high prevalence and 34 
morbidity (Tao, Shi, & Zhao, 2015). Recurrent infections are caused by reduced immunity, a 35 
phagocytic function associated with hyperglycemia and poor vascularization (Baltzis, 36 
Eleftheriadou, & Veves, 2014; Boulton, 2013; Dinh et al., 2012; Hilfiker, Kasper, Hass, & 37 
Haverich, 2011). Cell therapy with bone marrow mesenchymal stem cells has proved to be 38 
an effective tissue repair strategy. Although the pathways involved in this repair process have 39 
not been fully identified, it is known that transplanted cells release growth factors that 40 
modulate the immune response, organize tissues, promote angiogenesis and stimulate cell 41 
differentiation. Tissue engineering can aid in the regenerative process by developing new 42 
biomaterials that can regenerate wounds, prevent contractions and protect against infectious 43 
agents. The tissue repair process occurs in three distinct phases: inflammation, formation 44 
and remodeling of new tissue (Baltzis et al., 2014; Boulton, 2013; Dinh et al., 2012; Hilfiker 45 
et al., 2011). Besides mitigating the inflammatory process, effective wound healing dressings 46 
must have the following characteristics: wound adherence, histocompatibility, fluid loss 47 
control and sterility. 48 
In tissue engineering applications, biopolymers are of great interest in the manufacture of 49 
three-dimensional supports for cell culture and transplant. Chitosan (CHS) has been shown 50 
to be a highly suitable biopolymer for these applications (Ching Ting Tsao et al., 2011; Hilmi 51 
et al., 2013; T. Jiang et al., 2010; Moise et al., 2012). In addition to its good biocompatibility 52 
and non-toxicity, CHS has properties of particular interest as a wound-healing dressing, such 53 
as antimicrobial activity and excellent hemostatis (Ouyang et al., 2018)⁠. However one of its 54 
limiting factors is that it is not soluble in most organic solvents, although it can be dissolved 55 
in diluted acid solutions, and this hinders its use in the manufacture of complex structures. 56 
Chitosan has reactive amine and hydroxyl side groups occurring in the polymer chains, which 57 
can be modified by derivatization (Andrade et al., 2011; Casettari et al., 2012; Merchant et 58 
al., 2014). Alkaline treatment has also been used to reduce its molecular weight, if required 59 
(Barikani, Honarkar, & Barikani, 2010). These characteristics make it versatile to being 60 
 
modified by grafting specific side groups or complexing with other classes of polymers. 61 
Polyurethanes (PUs) synthesized in aqueous dispersion have recently attracted much 62 
attention due to their physicochemical properties and biocompatibility (X. Jiang et al., 2007; 63 
Rowlands, Lim, Martin, & Cooper-White, 2007; Wang, Ping, Chen, & Jing, 2006; Zuber, Zia, 64 
Mahboob, Hassan, & Bhatti, 2010). The polyester poly (DL lactide-co-glycolide) (PLGA) is 65 
the most frequently used polyester in the synthesis of PU-based biomaterials. It has been 66 
approved by the FDA for different applications and has been used for many years in the 67 
development of medical devices as well as in raw materials for the pharmaceutical industry. 68 
Another of its benefits is that its hydrolysis products can be uptaken in the cellular metabolic 69 
pathway (Jovanovic et al., 2010; Page et al., 2012)⁠.  70 
Bioresorption of CHS takes place by the enzymatic degradation of the polymer chains, 71 
although this is a slow process and depends on the location of the implant. Our hypothesis 72 
is that combining chitosan in a block copolymer network with other polymers susceptible to 73 
hydrolytic degradation will allow fast degradation of the material in aqueous media while 74 
maintaining the hydrogel behavior characteristic of chitosan and its proven regeneration 75 
capacities. This hypothesis is based on previous works on polymer blends or block 76 
copolymers containing chitosan as one of the components  (Ünlü, Pollet, &  Avérous, 2018, 77 
Gámiz-González, Vidaurre, & Gómez Ribelles, 2017; Hu et al., 2012; Dunia M. García Cruz, 78 
Gomez Ribelles, & Salmerón Sánchez, 2008 )⁠. The novelty of this work was synthesizing PU-79 
chitosan hydrogel membrane (HPUC) by introducing the PLGA blocks into soft PU segments. 80 
The hydrogel was formed in two steps, with the reaction of PU prepolymer via aqueous 81 
dispersion with unmodified chitosan. In this way, we produced a hydrogel for wound healing 82 
by combining CHS and PLGA blocks in a block copolymer network. Thus, we took advantage 83 
of PLGA’s hydrolysis properties to control degradation. After the physical and chemical 84 
characterization of the hydrogel membrane, a biocompatibility test was performed with bone 85 
marrow mononuclear cells (BMMNC) before evaluating the membrane combination as a 86 
wound-healing dressing and for BMMNC injections in a rat diabetic model. The promising 87 
results provided evidence that HPUC plus BMMNC may be used to enhance the wound 88 
healing process. 89 
2. Experimental 90 
2.1. Materials 91 
 
Chitosan [poly-(a-1/4)-2-amino-2-deoxy-D-glucopyranose] was purchased from Sigma-92 
Aldrich with viscosity-average molecular weight of 1500 kDa determined by Mark-Houwink 93 
equation using 0.1M CH3COOH/0.2M NaCl as a solvent system at 25ºC and average 94 
deacetylation degree (DD) of 75% determined by first derivative UV spectrophotometry 95 
(Dunia Mercedes García Cruz, Salmerón-Sánchez, & Gómez-Ribelles, 2012).  96 
Hexametylene diisocyanatee (HDI), 2,2- bis(hydroxymethyl) propionic acid (DMPA), 97 
Triethylamine (TEA), Tin(II) 2-ethylhexanoate, (3S)-cis-3,6-Dimethyl-1,4-dioxane-2,5-dione 98 
(L-Lactide), 1,4-Dioxane-2,5-dione (glycolide) and Streptozocinwere purchased from Sigma-99 
Aldrich. All materials were used as received without further purification. 100 
2.2. Membranes preparation 101 
The hydrogel based on waterborne polyurethane-chitosan (HPUC) was obtained from a 102 
polyurethane prepolymer and chitosan. The PU prepolymer was obtained from a polyester 103 
diol, previously synthetized, HDI and DMPA. Chitosan was used as received. 104 
2.2.1. Synthesis of the polyester diol 105 
The poly(lactid-co-glycolide)diol (PLGAdiol) was synthesized according to Ivirico et al. (2009) 106 
(Escobar Ivirico, Salmerón-Sánchez, Gómez Ribelles, & Monleón Pradas, 2009), with some 107 
modifications for obtaining a polyester copolymer with Mn of 2000 Da, from a mixture of 50:50 108 
of lactid acid and glycolide. Briefly, for this purpose 0.06 mol of lactide and 0.06 mol of 109 
glycolide were reacted with 0.01 mol of ethylene glycol at 120ºC for 4 hours at 23 mbar. After 110 
synthesis, the polymer was dissolved in acetone, precipitated in hexane under stirring and 111 
dried in a vacuum. 112 
2.2.2. Synthesis of the PU prepolymer 113 
All PU prepolymers were obtained at a ratio 2/1/1 of NCO groups in HDI / OH groups in 114 
PLGAdiol / OH groups in DMPA with 7% (wt%) of the internal emulsifier DMPA in relation to 115 
the polyester diol. The internal emulsifier was 100% neutralized with TEA. The amounts of 116 
PLGAdiol for each HPUC series are listed in Table 1. The reaction was carried out in a three-117 
necked round bottom flask using the adequate amounts of the polyester diol PLGA, HDI, 118 
DMPA and Tin(II) 2-thylhexanoate in 5 mL of  dimethyl sulfoxide. The reaction proceeded at 119 
70 °C for 2h under N2 atmosphere and magnetic stirring. TEA was then added to neutralize -120 
COOH groups of DMPA, and the reaction medium stirred for 30 min. 121 
 122 
 
2.2.3. Synthesis of hydrogel based waterborne polyurethane-chitosan (HPUC).   123 
Chitosan (0.01 g/mL) was solubilized in a 1% acetic acid solution for 45 min at 40 °C in an 124 
ultrasonic bath. Before use, the Chitosan solution was filtered (45 µm filter) and transferred 125 
to an addition funnel. The Chitosan solution was added dropwise to the PU prepolymer 126 
solution under stirring at 70 °C. After homogenization, the final solution was cast in a 127 
poly(tetrafluor ethylene) Petri dish and kept in an air circulating oven at 60 °C for 24h to allow 128 
the cross-linking reaction and solvent evaporation. The membranes thus formed were 129 
washed by immersion in deionized water for three days, changing the water every day. The 130 
membranes were finally washed with acetone in a refluxing apparatus for 4 h and then dried 131 
in a vacuum at room temperature. 132 
2.3. Characterization of HPUC membranes 133 
Infrared spectroscopy was performed on a Perkin-Elmer Spectrum 100 FT-IR (ATR) 134 
spectrometer. Solid- state 13C NMR was performed on an Agilent DD2 500MHz (11.7T)  NMR 135 
spectrometer. Thermogravimetric analyses were conducted on a Mettler-Toledo  136 
TGA/SDTA851e –FL1600. The samples were heated from 30°C to 900°C at a 10 °C/min 137 
heating rate in an N2 atmosphere (50ml/min). 138 
2.4. Solubility test and water uptake 139 
The dry samples were cut into pieces weighing around 50 mg. For solubility tests, the 140 
samples were immersed in each solvent in a vial and shaken at room temperature. The water 141 
uptake of the samples after being immersed for different times was evaluated as: 142 
 143 
S= [(Mf- Mi/)Mi]* 100, where: 144 
 145 
Mi is the weight of the dry sample at time t = 0 s and Mf is the weight of the wet sample at 146 
immersion time t. 147 
2.5. Degradation test   148 
The dry samples were cut into pieces weighing around 50 mg and immersed in a vial with 149 
phosphate buffered saline, PBS (pH 7.4). The samples were placed in a shaking incubator at 150 
37 °C. Buffer was changed weekly. All tests were performed in triplicate. After the periods of 151 
evaluation, the samples were removed from the buffer, gently dried with a filter paper and 152 
 
washed three times with deionized (DI) water and then dried in an oven for 24 hours at 60 °C 153 
and immediately weighed.  154 
The degradation ratio was determined according to the following equation: 155 
 156 
Wl =  [(Wf- Wi/)Wi]*100 ; were: 157 
 158 
Wl= weigth loss, Wi= Initial dry weight, Wf= dry weight after time degradation, 159 
 160 
The results shown are the average of 3 replica.  161 
 162 
Table 1 163 
 Amounts of reactants for the synthesis of HPUC series. 164 
 NCO/OH 2:1:1 
Sample PLGAdiol (g) DMPA/PLGAdiol  
(wt%) 
CS (g) Swelling 
Capacity (wt%) 




HPUC2 0.5 0.5 1800 
HPUC3 0.75 0.25 2000 
 165 
2.6. In vitro and in vivo assay 166 
This study was published and approved by the Health Sciences Commission of the School 167 
of Medicine of the Pontifícia Universidade Católica do Rio Grande do Sul - PUCRS under 168 
number 6236, and also by the Committee on Ethics in the Use of Animals - PUCRS, 169 
registered under number 15/00469. All procedures and techniques used during the animal 170 
experimentation are in accordance with the regulation proposed in the Brazilian Guidelines 171 
for the Care and Use of Animals for Scientific Purposes, by the National Council for the 172 
 
Control of Animal Experimentation (CONCEA, 2013) and the Ethics Committee for Use of 173 
Animals of PUCRS (CEUA). 174 
2.6.1. Mononuclear Bone Marrow Fraction isolation (BMMNCs) 175 
After euthanasia the donor animals were dissected and bone marrow was aspirated from the 176 
long bones. The aspirated material was placed in falcon tubes containing RPMI medium and 177 
was transferred to another tube containing FicollPaque (Histopaque 1119, Sigma Aldrich) and 178 
centrifuged at 400 g. The mononuclear cell layer was collected and washed with Dulbecco’s 179 
Phosphate Buffered Saline (DPBS). Viability was then determined using the trypan blue 180 
exclusion method. The same procedure was used for the tissue regeneration assay. 181 
2.6.2. Cell culture 182 
The cytotoxicity assay was performed with the adherent cell fraction. The cells were cultivated 183 
until confluence in a 75 cm2 cell culture flask containing Dulbecco’s modified Eagle’s medium 184 
(DMEM), supplemented with 10% of Fetal Bovine Serum (FBS), gentamicin (0.025 g/L and 185 
streptomycin/penicillin (0, 1 g/L) in humid atmosphere at 37 oC with 5% of CO2. 186 
2.6.3. MTT assay 187 
Cytotoxicity was evaluated according to ISO 10993-5, evaluating the mitochondrial function 188 
by tetrazolium salt reduction (MTT). The sample extracts were prepared in DMEM. After 189 
sterilization with ethanol, the HPUC membranes were washed by immersion in sterile Milli Q 190 
water three times and then once in DPBS and DMEM without FBS, immersed in DMEM 191 
medium for 24, 48 or 72 hours and incubated with stirring in a humid atmosphere at 37°C 192 
with 5% of CO2. DMEM medium was used as negative control and copper sulfate (0.1 g.mL-193 
1) in DMEM medium as positive control. All membranes were cut to a size of 3 cm2 and were 194 
incubated in 5 ml DMEM to allow the extraction. The BMMNCs suspension was adjusted and 195 
seeded at a density of 0.5 x104 cell per well onto 96-well culture plates and incubated for 24 196 
hours to allow cellular adhesion. The cells were then incubated for 24 h with DMEM and after 197 
that, the reading was performed. The absorbance values obtained were normalized by 198 
negative control with 100% viable cells. All the tests were performed in triplicate. 199 
2.6.4. Direct contact 200 
The cells were seeded at a density of 5 x 104 cells per well onto a 24-well culture plate.  The 201 
membrane was cut into a small circle (11-mm diameter) and placed in the middle of a well 202 
and incubated for 24 hours, 48 hours and 72 hours in humid atmosphere at 37°C with 5% of 203 
 
CO2. Cell viability was evaluated by the Live/Dead Cell Viability Assay on an Inverted Phase 204 
Contrast Fluorescence Microscope (Thermo Fischer Scientific) according to the 205 
manufacturer’s instructions. 206 
2.6.5. Animal model of diabetic ulcers 207 
60 day-old adult female Wistar rats weighing between 200 and 300g were given water and 208 
food ad libitum. Tail blood was collected at time 0 to evaluate the glycemic levels. All animals 209 
were fasted for 8 hours prior to diabetes induction, which was by an intraperitoneal injection 210 
of Streptozocin (70 mg/kg). Seven days after the streptozotocin injection the blood glucose 211 
levels of the animals were measured by the Accu-Check Active kit (Roche Diagnostics 212 
GmbH). The animals with blood glucose levels above 250mg/dL were considered diabetic. 213 
After glucose measurement, the animals were divided into two groups as described below.  214 
The animals submitted to the simulated ulcer procedure were given anesthesia of 80% 215 
Ketamine and 20% Chlorpromazine, followed by a dorsal incision of about 6mm diameter 216 
with a scalpel to simulate an ulcer wound. 217 
2.6.6. Experimental Design and Treatment of Groups 218 
In the in vivo evaluation for minimizing the use of animals, only HPUC1 membrane was 219 
selected because it is less fragile than HPUC2 and HPUC3 because its water sorption 220 
capacity is smaller while cytotoxicity results were similar in the three samples (see below) . 221 
The 16 rats were divided into 2 groups: Group 1 (control) (n=8): diabetic animals, with a 222 
wound, without treatment; Group 2 (n=8): diabetic animals with HPUC and BMMNCs 223 
transplanted onto the wound site. After the formation of the wound, 1x106 cells of the 224 
mononuclear bone marrow fraction were transplanted into each animal in Group 2 by injection 225 
into the edge of the wound. After this procedure, the HPUC was positioned and sutured onto 226 
the wound. The animals were evaluated histologically in two different periods of time: 7 and 227 
14 days after membrane implantation. 228 
2.7 Histopathology of diabetic mice wounded skin tissues 229 
Samples obtained from the histological analyses of the wound were removed 7 and 14 days 230 
after wound formation. To obtain the sample, the wounded area was removed from the 231 
animals backs after euthanasia in the CO2 chamber. All the samples were fixed in neutral 232 
buffered formalin and embedded in paraffin wax. Each section was 4μm thick and stained 233 
with hematoxylin-eosin (H&E). The analysis of the epithelial tissue and the depth of the 234 
epithelial cell-covered wound were considered. The analysis of connective tissue was 235 
 
considered for the study of the inflammatory process, measured by the type and quantity of 236 
inflammatory cells and presence / absence of fibrosis, using H&E staining. The analyses were 237 
performed by two blinded examiners, previously instructed by a pathologist and calibrated by 238 
the kappa coefficient test. 239 
 2.8.  Macroscopic wound closure analyses 240 
The closure of the wounds was measured by comparing with ImageJ software the images 241 
recorded during the experiments. The formula used to measure the wound regeneration rate 242 
was as follows: 243 
 244 
RWA = (DA)/(OWA)*100;  were: 245 
 246 
RWA: Residual wound área (%), DA: Detected Area, OWA: Original Wound Area. 247 
 248 
2.9. Statistical Analysis 249 
Quantitative data was expressed as mean ± standard deviation. To compare the regeneration 250 
of the wound between the groups, an unpaired t test was perfomed at each time to compare 251 
the difference in wound closures. Values with p <0.05 were considered statistically significant. 252 
All the statistical analyses were performed with the statistical GraphPad Prism. 253 
3. Results and discussion 254 
3.1 Synthesis of hydrogel membranes 255 
The chitosan waterborne polyurethane was obtained in two stages as shown in the reaction 256 
scheme in Figure 1. The first (i) step consisted of the synthesis of the polyurethane 257 
prepolymer (PU prepolymer) with different weights of the soft segment poly (lactide-co-258 
glicolide) diol, with HDI and DMPA as a chain extensor. In the second (ii) step, the HPUC was 259 
obtained by crosslinking reaction of the PU prepolymer with chitosan during membrane 260 
formation.  261 
The synthesized membranes to be used as wound dressings were successfully obtained as 262 
shown in Figure 1. However, the membrane (HPUC3) with the highest amount of prepolymer 263 
(75%) became more brittle than the others (Figure S1 in Supplementary Material). This could 264 
have been due to the membrane presenting a phase separation, which may have contributed 265 
 
to the immiscibility of the components and making it brittle (Tg 15 °C, data not shown). This 266 
was not observed in the other two membranes. 267 
 268 
 269 
Fig. 1. Synthesis route of the HPUC membranes. 270 
 271 
3.2. Swelling 272 
Chitosan was soluble in acetic acid 1% while the prepolymers were soluble in DMSO, acetone 273 
and CHCl3. The membranes were not soluble in the solvents used to solubilize the 274 
prepolymer or in acetic acid 1%, proving the formation of crosslinked networks. Sample 275 
weight in immersion in liquid water stabilizes after 48 hours (See Figure S2 in Supplementary 276 
Material). The water sorption capacity at 48 hours for the different samples is larger than 277 
1000% measured on dry basis (Table 1). The network swelling capacity confirms that, 278 
 
contrary to what could be expected, the membrane with the highest hydrophobous 279 
component, HPUC3, had the highest water uptake. The water content measured at 48 hours 280 
of immersion time thus fell from about 2000 to 1200 when the PLGA content was reduced 281 
from 75% to 25% (samples HPUC3 and HPUC1).The figure does not show a curve for pristine 282 
chitosan because it is water soluble, since the amine groups remain protonated after 283 
dissolution in the acidic medium. Hydrogel equilibrium water content is described by the Flory 284 
Rhener Equation (Flory & Rehner, 1943), which shows that swelling increases with a 285 
favorable water-polymer segment interaction parameter and with the higher average 286 
molecular weight between crosslinks in the network, i.e. with a reduced crosslinking density. 287 
The higher PLGA/CHS ratio should yield a less favorable average interaction parameter 288 
between PU soft segments and water. The fact that swelling capacity nevertheless increases 289 
could be due to less efficient crosslinking with the presence of a significant number of 290 
unreacted carboxyl end groups in PU prepolymer. 291 
3.3. FT-IR of chitosan polyurethane. 292 
The spectra of original chitosan and polyurethane based on chitosan with different soft 293 
segment contents are shown in Figure 2A. 294 
The chitosan spectrum shows the typical large peaks in the 3340 cm-1 region relative to the 295 
stretching of the OH and NH2 groups, 2872-2920 cm-1 to CH2 stretch, 1151 cm-1 for C –O 296 
–C of the chitosan ring. The appearance of the peaks relative to urea and urethane bonds 297 
can be observed in the case of polyurethane prepolymer and the networks. The membrane 298 
formed has two hard segments due to the urea and urethane bonds formed between the 299 
diisocyanate groups and NH2 and OH chitosan groups and PLGA/DMPA, respectively 300 
(Subramani, Park, Lee, & Kim, 2003). These urethane bond peaks appear in the 1730-1746 301 
cm-1 region (C=O stretch), 1027-1074 cm-1 (C-O stretch) and urea bonds at 1616 -1625 cm-302 
1 (C=O stretch), 1589 cm-1 (NH bending) and 1254 – 1260 cm-1 (C-N stretch). As found by 303 
other authors, the urea bond formation (-NHCONH-) occurs because the preferential 304 
reactivity of NCO groups with NH2 groups is much more reactive than the OH groups (S. H. 305 
Chen et al., 2012; Pérez-Limiñana, Arán-Aís, Torró-Palau, Orgilés-Barceló, & Martín-306 
Martínez, 2005; Velazquez-Morales, Le Nest, & Gandini, 1998).   307 
In the supplementary data, Figure S3, the FTIR spectra of the synthesized PLGAdiol and the 308 
PU prepolymer are shown. Although is observed an overlapping in the urethane and urea 309 
absorption region the peaks around 1600-1750 cm-1 are distinguishable. The presence of 310 
 
the absorption band at 1625 cm-1, which is ascribed to hydrogen-bonded urea groups 311 
(Marchant, Zhao, Anderson, & Hiltner, 1987; Zhang, Ren, He, Zhu, & Zhu, 2007) and is 312 
absent in the prepolymer is slightly different in the networks with varying composition, 313 
showing that sample composition affects the reaction mechanism.  314 
 315 
   316 
Fig. 2. FTIR spectrum of membranes. (A) Membranes before the degradation test. Arrows 317 
and lines indicate the main groups related to crosslinking between the prepolymer PU and 318 
CHS (in black: CHS, red: HPUC1, blue: HPUC2 and green: HPUC3). (B) Membrane 319 
HPUC2 after 8 weeks immersion in PBS 1x buffer. 320 
 321 
3.4. Solid state 13C-NRM 322 
Figure 3 shows the solid state NRM spectra of chitosan and HPUC membranes with 25% 323 
(HPUC1), 50% (HPUC2) and 75% (HPUC3) soft segment. In chitosan the peaks in Figure 3 324 
are those of C1 (δ104.8), C4 (δ81.5), C5 and C3 (δ75.1), C6 and C2 (δ57.2), and CH3 (δ22.6), 325 
in agreement with other studies (de Moura, Aouada, & Mattoso, 2008; Heux, Brugnerotto, 326 
Desbrières, Versali, & Rinaudo, 2000). For HPUC membranes we observed novel peaks, 327 
which have been reported as the chitosan-PU crosslinking for HPUC1 peaks:  δ174.82, 328 
δ159.27, δ99.49, δ73.24, δ60.60, δ41.65, δ29.50, δ17.34; for HPUC2: δ176.77, δ159.76, 329 
δ101.92, δ73.24, δ61.09, δ41.65, δ29.98, δ16.86 and HPUC3: δ174.34, δ159.27, δ102.40, 330 
δ74.40, δ60.60, δ42.13, δ30.64, δ23.13. The carbonyl (CO) shifts are far from the field (155-331 
210 ppm) and generally weak due to slow relaxation. For urea and urethanes the shifts are 332 
170-180 and 150-160, respectively.  The peak of 13C spectra in the urea group occurs at a 333 
 
higher magnetic field than those in the urethane group (Zhang, Cheng, & Hu, 2003)�. The 334 
displacement, found in HPUCs around δ174, is related to urea bounds between –NH2 groups 335 
of chitosan and -NCO groups of PU prepolymer, while δ159 is related to both urethane bonds 336 
-NHCOO- of polyester and DMPA in the soft and hard segments, respectively (Barikani et al., 337 












Fig. 3. Solid state 13C-NRM spectrum of membranes. Arrows indicate the main shifts 350 
related to crosslinking between the prepolymer PU and CHS (in black: CHS, red: HPUC1, 351 
blue: HPUC2 and green: HPUC3). 352 
3.5 Thermogramymetric analysis 353 
Figure 4B show the derivative weight loss (DTG) curves of chitosan and HPUC membranes.  354 
In the chitosan and HPUC TG curve we observed the first thermal event in the 40-140°C 355 
range, which indicates a weight loss of less than 6% attributed to the evaporation of residual 356 
water from the polymer (de Britto & Campana-Filho, 2007)�.  The second thermal event, 357 
after 140 °C, is due to the overlapping of the degradation of chitosan and PLGA chains. 358 
Thermal degradation of the chitosan used in this study takes place in the 187-372 °C range 359 
(with a maximum in the DTG plot at 268 °C) and is attributed to the thermal decomposition of 360 
chitosan chains (Abused et al., 2014; Neto et al., 2005; Zawadzki & Kaczmarek, 2010)�. For 361 
HPUCs, thermal decomposition in the TG curve occurs in a broader temperature range 362 
 
between 142 and 502°C. The overlap of the different phenomena can best be seen in the 363 
DTG curve (Figure 4B). 364 
The peak appearing at the lower temperature is attributed to the degradation and weight loss 365 
of the hard and soft segments of the urethane groups (the intensity of this peak increases 366 
with increasing PLGA content, as expected). This peak appears at temperatures lower than 367 
that of pure chitosan degradation (the maximum in DTG curve appears at ~235ºC). On the 368 
high temperature side of this peak, in the chitosan degradation temperature range a shoulder 369 
can be seen indicating the decomposition of chitosan chains in the network. The highest 370 
temperature peak in the HPUCs is relative to the weight loss of the hard segment of the urea 371 
bond, since the energy of the urea bond is larger than that of the urethane bond, the 372 
degradation peak in urea appears at higher temperatures (García-Pacios, Costa, Colera, & 373 
Martín-Martínez, 2011). Table 2 gives the chitosan and HPUC thermal data. HPUC 374 
membranes had a lower onset temperature, HPUC1> HPUC2> HPUC3, with PLGA 375 
incorporated in the chitosan structure, which could be associated with changes in the 376 
intermolecular interactions between polysaccharide chains resulting in reduced polymer 377 
thermal stability. 378 
 379 
 380 
Fig. 4. Graphs of the relative weight loss curves (A) and derived weight loss (B) of chitosan 381 
membranes and HPUCs (in black: CHS, red: HPUC1, blue: HPUC2 and green: HPUC3). 382 
 383 
 
Table 2 384 










CHS 187-372 268  30 
HPUC1 171-476 232.5 426 36 
HPUC2 151-507 232.5 435 40 
HPUC3 142-507 237 435 41 
 386 
3.6. Degradation in PBS medium 387 
Figure 5 shows the degradation curves in an aqueous solution (PBS 1x pH 7.4) for up to eight 388 
weeks. There is a significant mass loss at the end of the eight weeks in the HPUC2 and 389 
HPUC3 samples, 87.0% and 90.5% respectively, compared to 56.4% for HPUC1 and 53.2% 390 
for CHS.  The findings show that membrane weight loss has two different mechanisms. Since 391 
the membranes were not neutralized at the end of the synthesis, one could expect that the 392 
chitosan chain amine groups would remain protonated and that the chitosan would be slowly 393 
dissolved in the aqueous solution. Thus, the pure chitosan film presents a continuous weight 394 
loss of up to 53.2%, which cannot be explained by hydrolysis. This delivery of chitosan chains 395 
by dissolution in the aqueous medium is prevented in the HPUC hydrogels by the polymer 396 
network structure. Nevertheless, HPUC2 and HPUC3 membranes can degrade by nearly 397 
100% in eight weeks. Since cleavage of chitosan chains by hydrolysis does not take place in 398 
the degradation times of our experiments, we hypothesize that the cleavage of the PLGA 399 
chains and urea linkages liberates chitosan chains that are susceptible to being dissolved in 400 
the medium, since they are protonated, contributing to the weight loss (See the schema in 401 
Figure S4 of supplementary material).  402 
FTIR analysis support this assumption. After eight weeks of degradation of the HPUC 403 
membranes (Figure 2B) it is clear the disappearance of the peaks characteristic of the PU 404 
 
regions between 1500-1150 cm-1, and the strong band at approximately 1745 cm-1 405 
corresponding to a C = O bond of ester groups showing the degradation of the PLGA segment. 406 
In addition, the original position of the amide peak at 1579 cm-1 (C-N and N-H) moves to 407 
1575 cm-1 (Figure 2B). It is also possible to visualize the displacement of the 1625 cm-1 408 
peak for 1619 cm-1 corresponding to the carbonyl bond in the urea groups (C = O amide I) 409 
indicating degradation of the rigid segment ((Marcos-Fernández, Abraham, Valentín, & 410 
Román, 2006; Pretsch, Jakob, & Müller, 2009), the same can be seen in the 1530 cm-1 region 411 
referring to PU urethane group bound to the CHS chains.  412 
The high swelling capacity of the HPUC network, even for the largest PLGA content, 413 
contributes to the hydrolysis process. PLGA chains are exposed to water molecules in the 414 
swollen sample and thus the hydrolysis of the ester groups is faster than in bulk PLGA which 415 
is highly hydrophobous.  416 
Thus, we propose that the fast, and nearly complete degradation of the HPUC hydrogels is 417 
due to the combination of the loose of the degradation fragments of PLGA chains together 418 











Fig. 5. CHS and HPUC mass loss curves after up to eight weeks: ■ CHS, ● HPUC1, 430 




3.7. In vitro cytotoxicity analysis of HPUC membranes   434 
To select the best membrane to continue the in vivo assay we evaluated cellular viability by 435 
mitochondrial metabolic activity. For the indirect cytotoxicity analysis, the adherent BMMNCs 436 
were cultured with membrane extracts obtained after immersion of the membranes for 437 
periods of 24, 48 and 72 hours. The viability of the cells cultured in direct contact with HPUC 438 
membranes in the same time periods was assessed with a live/dead test with fluorescence 439 
microscopic evaluation. In all the exposure periods in the indirect contact experiment the 440 
viability was of all the membranes above 80% of the negative control (Figure S5 in 441 
Supplementary Material) 442 
Considering the results obtained for HPUC3 degradation time and brittleness in the swelling 443 
experiments, we opted for HPUC1 and HPUC2 membranes to continue the evaluation. The 444 
HPUC1 and HPUC2 networks were analyzed in direct contact using the live/dead 445 
fluorescence assay, which provides information on physical cell properties (cellular 446 
membrane integrity) and biochemical intracellular esterase activity (Masson-Meyers, Bumah, 447 
& Enwemeka, 2016). No cytotoxicity effect was detected (see images in Figure 6), indicating 448 
that the cells produced esterase (green fluorescence), which is an indicator of viable cells, 449 
while the red fluorescence that indicates cell death is rarely observed. The images show the 450 
cells well spread out on the culture plate, while the morphology and cell numbers are quite 451 
similar to those of the controls. 452 
3.8. HPUC plus BMMNCs accelerated wound repair in diabetic rats   453 
Considering the high costs of treating patients with ulcers in the lower limbs, and the high 454 
morbidity and mortality rate caused by this type of wound, the research for new treatments is 455 
necessary. Diabetic patients affected by ulcers in the lower limbs go through a prolonged 456 
inflammatory phase during tissue regeneration, with persistence of a pro-inflammatory profile, 457 
moving from an acute to a chronic state. This prolonged inflammation is directly related to the 458 
precarious healing of these wounds, leading these individuals to recurrent infections, and 459 
when not properly treated at an early stage, can lead to amputation. Our study aimed to 460 
identify whether the use of a biological dressing associated with mononuclear bone marrow 461 
fraction cells from rats would be able to improve the regenerative response in ulcerous 462 
wounds in diabetic rats. 463 
From an intraperitoneal use of streptozotocin, it was possible to establish an animal model of 464 
diabetes. After the model was established, we were able to create a wound on the animals’ 465 
 
backs to simulate an ulcer wound, simulating the ulcer shown in lower limbs from diabetic 466 
individuals. From the results, it was observed that the group of animals treated with the HPUC 467 
combined with the injection of BMMNCs in the interphase between the tissue and the HPUC 468 
membrane (Group 2) showed significantly better results in terms of healing in the first 7 days 469 
after the formation of the wound compared to the control group (Figure 7). During the first few 470 
days, we observed that the animals that had the HPUC plus BMMNCs on the wound had a 471 
cleaner and drier wound, when compared macroscopically with the animals that did not 472 
receive the treatment.  This suggests that the membrane achieved hemostasis of the wound, 473 
supporting the formation of the fibrin matrix and cell infiltration (Eming, Martin, & Tomic-canic, 474 




Fig. 6. Representative fluorescent image of MSCs: (A – F) Control, (G– M), HPUC2, (N – 478 
S) HPUC1. Live cells were stained with calcein AM (green) using a FITC filter and dead 479 
cells were stained with Ethidium homodimer (red) and captured by an PI filter. All images 480 
were acquired after 24, 48 and 72 hours. Magnification 100x. 481 
 
In addition, the animals treated with the BMMNCs plus the biomaterial showed a significantly 482 
better regeneration rate than those from the control group after 14 days, with a significant 483 
reduction in wound size. 484 
  The use of bone marrow-derived mesenchymal cells enhances tissue regeneration, 485 
significantly reducing the wound size in rat diabetes ulcer models using streptozotocin.  In 486 
addition, complete wound healing time was also significantly lower in the mesenchymal cell 487 
treated group (Kuo et al., 2011). The combination BMMNCs and HPUC provided wound 488 
healing in just 14 days (wound closure >90%). Although previous studies in the literature with 489 
different biomaterials showed a significant improvement of wound healing, they required 490 
longer times and a more intense inflammatory process (Ahmed et al., 2018; Sayed et al., 491 
2016). The macroscopic analysis of wounds treated with these membranes revealed a 492 
considerably smaller wound bed than those in the control group. 493 
 494 
 495 
Fig. 7. Representative image in the effects of HPUC1 and BMMNCs on wound healing in 496 
diabetic ulcer model. (A) Macroscopic observations in wound areas in the control (G1) and 497 
wound healing contraction induced by HPUC1 plus BMMNCs (G2). (B) Residual wound area. 498 
The results are expressed as mean ± standard deviation (n= 6). (*) indicates significant 499 
difference,  p< 0.05. 500 
3.9. Histological wound healing by H&E staining 501 
To evaluate the role of BMMNCs in the remodeling and speed of tissue regeneration when 502 
transplanted with a HPUC membrane, we collected the samples from the wound region in 503 
the diabetic rats for histological analysis on days 7 and 14. On day 7 it was observed a 504 
 
noticeable difference on wound closure from the treated group (Figure 8) compared to the 505 




Fig. 8. Representative histologic analysis of the wound region. Tissue samples were 510 
collected on day 7 (A, E, C, G) and 14 (B, F, D, H). H&E staining showed severe 511 
nflammation in the control group (A, B, E, F) and wound healing and re-epithelialization (C, 512 
D, G, H) in the HPUC1 plus BMMNC group. Black arrows indicate inflammatory cell 513 
infiltrate, black arrowhead fibroblasts and white arrowhead indicate blood vessels. 514 
Magnification 4x in A, E, C, D, and 20x in B, F, G, H. 515 
 516 
Unlike Group 2 (HPUC + BMMNCs), Inflammatory cell infiltrate was observed in the control 517 
group and there were no signs of epithelial regeneration. In Group 2, moderate inflammatory 518 
infiltrate was visible, together with wound closure with epithelization. On day 14 remodeling 519 
of the wound was clearly seen in Group 2 with organized connective tissue and 520 
neovascularization, indicating successful healing. This was not found in the control group. 521 
Initial inflammation at the beginning of healing is critical for the regeneration period, which 522 
dictates the second phase of wound regeneration, with reduced inflammation remodeling and 523 
culminating in wound closure (Koehler, Brandl, & Goepferich, 2018)�. All these processes 524 
involve several cell types. The mesenchymal cells in the BMMNC fraction of bone marrow 525 
aspirates may have a positive effect on the anti-inflammatory process for their differentiation 526 
 
and paracrine effects (L. Chen, Tredget, Wu, Wu, & Wu, 2008; Park, Ahn, Sung, Ahn, & 527 
Chang, 2018). Another important point was the large HPUC membrane water absorption 528 
capacity (shown in swelling tests). Better dressing water uptake could lead to different forms 529 
of exudate retention, which may cause changes in cytokine levels and growth factors on the 530 
wound surface and faster cicatrization (Yamane et al., 2015). 531 
  4. Conclusions 532 
This paper describes a study of synthesized chitosan/PLGA networks, which were found to 533 
present continuous degradation in aqueous solution. The hydrolytic degradation of 534 
polyurethane blocks liberated chitosan chains that dissolved in the aqueous solution. We 535 
confirmed that this biomaterial has low cytotoxicity and supports cell proliferation. The 536 
synthesis was based on unmodified chitosan and new crosslinkers consisting of a low 537 
molecular weight polyester polyurethane with NCO terminations, enabling crosslinking with 538 
free amine of chitosan. The use of BMMNCs helped to close the wounds, reduce 539 
inflammation and improve neovascularization around the wound. The results show that the 540 
synthesized hydrogel plus BMMNCs is suitable for use as a dressing for diabetic wounds and 541 
has a potential use in tissue engineering. 542 
Acknowledgments 543 
The author is grateful to Gabriela Wentz for technical assistance in RMN analysis, also to the 544 
Nuclear Magnetic Resonance Laboratory - Regional Nanoscience and Nanotechnology 545 
Laboratory (LNNANO) 546 
Funding: 547 
This work was funded by:  Coordenação de Aperfeiçoamento de Pessoal de Nível Superior 548 
- doctoral fellowships to Viezzer, C (CAPES/PDSE-BEX: 1408/11- 9) and the Spanish Ministry 549 
of Economy and Competitiveness (MINECO) through the MAT2016-76039-C4-1-R Project, 550 
including FEDER financial support. CIBER-BBN is an initiative funded by the VI National 551 
R&D&i Plan 2008–2011, Iniciativa Ingenio 2010, Consolider Program, CIBER Actions and 552 
financed by the Instituto de Salud Carlos III with assistance from the European Regional 553 
Development Fund. 554 
Reference 555 
  556 
Abused, W., Doe, J., Ad, G. R., Lo, B. I. O., Man, G.-H. U., Oach, A., … Ward, G. (2014). 557 
 
from the SAGE Social Science Collections . All Rights Reserved . Journal of Composite 558 
Materials, 16(4), 928–940. https://doi.org/0803973233 559 
Ahmed, R., Tariq, M., Ali, I., Asghar, R., Noorunnisa Khanam, P., Augustine, R., & Hasan, A. 560 
(2018). Novel electrospun chitosan/polyvinyl alcohol/zinc oxide nanofibrous mats with 561 
antibacterial and antioxidant properties for diabetic wound healing. International Journal 562 
of Biological Macromolecules, 120, 385–393. 563 
https://doi.org/10.1016/j.ijbiomac.2018.08.057 564 
Andrade, F., Goycoolea, F., Chiappetta, D. a., das Neves, J., Sosnik, A., & Sarmento, B. 565 
(2011). Chitosan-Grafted Copolymers and Chitosan-Ligand Conjugates as Matrices for 566 
Pulmonary Drug Delivery. International Journal of Carbohydrate Chemistry, 2011, 1–14. 567 
https://doi.org/10.1155/2011/865704 568 
Baltzis, D., Eleftheriadou, I., & Veves, A. (2014). Pathogenesis and Treatment of Impaired 569 
Wound Healing in Diabetes Mellitus: New Insights. Advances in Therapy, 31(8), 817–570 
836. https://doi.org/10.1007/s12325-014-0140-x 571 
Barikani, M., Honarkar, H., & Barikani, M. (2010). Synthesis and characterization of chitosan-572 
based polyurethane elastomer dispersions. Monatshefte Fur Chemie, 141(6), 653–659. 573 
https://doi.org/10.1007/s00706-010-0309-1 574 
Boulton, A. J. M. (2013). The pathway to foot ulceration in diabetes. Medical Clinics of North 575 
America, 97(5), 775–790. https://doi.org/10.1016/j.mcna.2013.03.007 576 
Casettari, L., Vllasaliu, D., Castagnino, E., Stolnik, S., Howdle, S., & Illum, L. (2012). 577 
PEGylated chitosan derivatives: Synthesis, characterizations and pharmaceutical 578 
applications. Progress in Polymer Science, 37(5), 659–685. 579 
https://doi.org/10.1016/j.progpolymsci.2011.10.001 580 
Chen, L., Tredget, E. E., Wu, P. Y. G., Wu, Y., & Wu, Y. (2008). Paracrine factors of 581 
mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance 582 
wound healing. PLoS ONE, 3(4). https://doi.org/10.1371/journal.pone.0001886 583 
Chen, S. H., Tsao, C. T., Chang, C. H., Wu, Y. M., Liu, Z. W., Lin, C. P., … Hsieh, K. H. (2012). 584 
Synthesis and characterization of thermal-responsive chitin-based polyurethane 585 
copolymer as a smart material. Carbohydrate Polymers, 88(4), 1483–1487. 586 
https://doi.org/10.1016/j.carbpol.2012.01.055 587 
Ching Ting Tsao, Chih Hao Chang, Yu Dar Li, Ming Fung Wu, Chun Pin Lin, Jin Lin Han, … 588 
Kuo Huang Hsieh. (2011). Development of chitosan/ dicarboxylic acid hydrogels as 589 
wound dressing materials. Journal of Bioactive and Compatible Polymers, 26(5), 519–590 
536. https://doi.org/10.1177/0883911511422627 591 
de Britto, D., & Campana-Filho, S. P. (2007). Kinetics of the thermal degradation of chitosan. 592 
Thermochimica Acta, 465(1–2), 73–82. https://doi.org/10.1016/j.tca.2007.09.008 593 
de Moura, M. R., Aouada, F. a, & Mattoso, L. H. C. (2008). Preparation of chitosan 594 
 
nanoparticles using methacrylic acid. Journal of Colloid and Interface Science, 321(2), 595 
477–483. https://doi.org/10.1016/j.jcis.2008.02.006 596 
Dinh, T., Tecilazich, F., Kafanas, A., Doupis, J., Gnardellis, C., Leal, E., … Veves, A. (2012). 597 
Mechanisms involved in the development and healing of diabetic foot ulceration. 598 
Diabetes, 61(11), 2937–2947. https://doi.org/10.2337/db12-0227 599 
Eming, S. A., Martin, P., & Tomic-canic, M. (2014). STATE OF THE ART REVIEW Wound 600 
repair and regeneration : Mechanisms , signaling , and translation. Science Translational 601 
Medicine, 6(265), 265sr6. https://doi.org/10.1126/scitranslmed.3009337 602 
Escobar Ivirico, J. L., Salmerón-Sánchez, M., Gómez Ribelles, J. L., & Monleón Pradas, M. 603 
(2009). Poly(L-lactide) networks with tailored water sorption. Colloid and Polymer 604 
Science, 287(6), 671–681. https://doi.org/10.1007/s00396-009-2026-z 605 
Flory, P. J., & Rehner, J. (1943). Statistical mechanics of cross-linked polymer networks II. 606 
Swelling. The Journal of Chemical Physics, 11(11), 521–526. 607 
https://doi.org/10.1063/1.1723792 608 
Gámiz-González, M. A., Vidaurre, A., & Gómez Ribelles, J. L. (2017). Biodegradable 609 
chitosan-poly(Ɛ-caprolactone) dialdehyde copolymer networks for soft tissue 610 
engineering. Polymer Degradation and Stability, 138, 47–54. 611 
https://doi.org/10.1016/j.polymdegradstab.2017.02.005 612 
García-Pacios, V., Costa, V., Colera, M., & Martín-Martínez, J. M. (2011). Progress in Organic 613 
Coatings Waterborne polyurethane dispersions obtained with polycarbonate of 614 
hexanediol intended for use as coatings. Progress in Organic Coatings, 71, 136–146. 615 
https://doi.org/10.1016/j.porgcoat.2011.01.006 616 
García Cruz, Dunia M., Gomez Ribelles, J. L., & Salmerón Sánchez, M. (2008). Blending 617 
polysaccharides with biodegradable polymers. I. Properties of chitosan/polycaprolactone 618 
blends. Journal of Biomedical Materials Research - Part B Applied Biomaterials, 85(2), 619 
303–313. https://doi.org/10.1002/jbm.b.30947 620 
García Cruz, Dunia Mercedes, Salmerón-Sánchez, M., & Gómez-Ribelles, J. L. (2012). 621 
Stirred flow bioreactor modulates chondrocyte growth and extracellular matrix 622 
biosynthesis in chitosan scaffolds. Journal of Biomedical Materials Research - Part A, 623 
100 A(9), 2330–2341. https://doi.org/10.1002/jbm.a.34174 624 
Heux, L., Brugnerotto, J., Desbrières, J., Versali, M. F., & Rinaudo, M. (2000). Solid state 625 
NMR for determination of degree of acetylation of chitin and chitosan. 626 
Biomacromolecules, 1(4), 746–751. 627 
Hilfiker, A., Kasper, C., Hass, R., & Haverich, A. (2011). Mesenchymal stem cells and 628 
progenitor cells in connective tissue engineering and regenerative medicine: Is there a 629 
future for transplantation? Langenbeck’s Archives of Surgery, 396(4), 489–497. 630 
https://doi.org/10.1007/s00423-011-0762-2 631 
 
Hilmi, A. B. M., Halim, A. S., Hassan, A., Lim, C. K., Noorsal, K., & Zainol, I. (2013). In vitro 632 
characterization of a chitosan skin regenerating template as a scaffold for cells cultivation. 633 
SpringerPlus, 2(2002), 79. https://doi.org/10.1186/2193-1801-2-79 634 
Hu, Y., Liu, Y., Qi, X, Liu, P., Fan, Z., Li, S. (2012) Novel bioresorbable hydrogels prepared 635 
from chitosan-graft-polylactide copolymers. Polym. Int, 61, 74-81. 636 
https://doi.org/10.1002/pi.3150 637 
Jiang, T., Nukavarapu, S. P., Deng, M., Jabbarzadeh, E., Kofron, M. D., Doty, S. B., … 638 
Laurencin, C. T. (2010). Chitosan-poly(lactide-co-glycolide) microsphere-based 639 
scaffolds for bone tissue engineering: In vitro degradation and in vivo bone regeneration 640 
studies. Acta Biomaterialia, 6(9), 3457–3470. 641 
https://doi.org/10.1016/j.actbio.2010.03.023 642 
Jiang, X., Li, J., Ding, M., Tan, H., Ling, Q., Zhong, Y., & Fu, Q. (2007). Synthesis and 643 
degradation of nontoxic biodegradable waterborne polyurethanes elastomer with 644 
poly(??-caprolactone) and poly(ethylene glycol) as soft segment. European Polymer 645 
Journal, 43(5), 1838–1846. https://doi.org/10.1016/j.eurpolymj.2007.02.029 646 
Jovanovic, D., Engels, G. E., Plantinga, J. a., Bruinsma, M., Van Oeveren, W., Schouten,  a. 647 
J., … Harmsen, M. C. (2010). Novel polyurethanes with interconnected porous structure 648 
induce in vivo tissue remodeling and accompanied vascularization. Journal of 649 
Biomedical Materials Research - Part A, 95(1), 198–208. 650 
https://doi.org/10.1002/jbm.a.32817 651 
Koehler, J., Brandl, F. P., & Goepferich, A. M. (2018). Hydrogel wound dressings for bioactive 652 
treatment of acute and chronic wounds. European Polymer Journal, 100(December 653 
2017), 1–11. https://doi.org/10.1016/j.eurpolymj.2017.12.046 654 
Kuo, Y. R., Wang, C. T., Cheng, J. T., Wang, F. S., Chiang, Y. C., & Wang, C. J. (2011). Bone 655 
marrow-derived mesenchymal stem cells enhanced diabetic wound healing through 656 
recruitment of tissue regeneration in a rat model of streptozotocin-induced diabetes. 657 
Plastic and Reconstructive Surgery, 128(4), 872–880. 658 
https://doi.org/10.1097/PRS.0b013e3182174329 659 
Leventis, N., Sotiriou-Leventis, C., Chandrasekaran, N., Mulik, S., Larimore, Z. J., Lu, H., … 660 
Mang, J. T. (2010). Multifunctional polyurea aerogels from isocyanates and water. A 661 
structure-property case study. Chemistry of Materials, 22(24), 6692–6710. 662 
https://doi.org/10.1021/cm102891d 663 
Marchant, R. E., Zhao, Q., Anderson, J. M., & Hiltner, A. (1987). Degradation of a poly(ether 664 
urethane urea) elastomer: infra-red and XPS studies. Polymer, 28(12), 2032–2039. 665 
https://doi.org/10.1016/0032-3861(87)90037-1 666 
Marcos-Fernández, A., Abraham, G. A., Valentín, J. L., & Román, J. S. (2006). Synthesis 667 
and characterization of biodegradable non-toxic poly(ester-urethane-urea)s based on 668 
 
poly(ε-caprolactone) and amino acid derivatives. Polymer, 47(3), 785–798. 669 
https://doi.org/10.1016/j.polymer.2005.12.007 670 
Masson-Meyers, D. S., Bumah, V. V., & Enwemeka, C. S. (2016). A comparison of four 671 
methods for determining viability in human dermal fibroblasts irradiated with blue light. 672 
Journal of Pharmacological and Toxicological Methods, 79, 15–22. 673 
https://doi.org/10.1016/j.vascn.2016.01.001 674 
Merchant, Z., Taylor, K. M. G., Stapleton, P., Razak, S. a., Kunda, N., Alfagih, I., … 675 
Somavarapu, S. (2014). Engineering hydrophobically modified chitosan for enhancing 676 
the dispersion of respirable microparticles of levofloxacin. European Journal of 677 
Pharmaceutics and Biopharmaceutics, 88(3), 816–829. 678 
https://doi.org/10.1016/j.ejpb.2014.09.005 679 
Moise, M., Sunel, V., Holban, M., Popa, M., Desbrieres, J., Peptu, C., & Lionte, C. (2012). 680 
Double crosslinked chitosan and gelatin submicronic capsules entrapping aminoacid 681 
derivatives with potential antitumoral activity. Journal of Materials Science, 47(23), 8223–682 
8233. https://doi.org/10.1007/s10853-012-6719-1 683 
Neto, C. G. T., Giacometti, J. a., Job,  a. E., Ferreira, F. C., Fonseca, J. L. C., & Pereira, M. 684 
R. (2005). Thermal analysis of chitosan based networks. Carbohydrate Polymers, 62(2), 685 
97–103. https://doi.org/10.1016/j.carbpol.2005.02.022 686 
Oberyszyn, T. M. (2008). Department of Pathology, The Ohio State University, Columbus, OH 687 
43210. (8), 2993–2999. 688 
Ouyang, Q. Q., Hu, Z., Lin, Z. P., Quan, W. Y., Deng, Y. F., Li, S. D., … Chen, Y. (2018). 689 
Chitosan hydrogel in combination with marine peptides from tilapia for burns healing. 690 
International Journal of Biological Macromolecules, 112, 1191–1198. 691 
https://doi.org/10.1016/j.ijbiomac.2018.01.217 692 
Page, J. M., Prieto, E. M., Dumas, J. E., Zienkiewicz, K. J., Wenke, J. C., Brown-Baer, P., & 693 
Guelcher, S. a. (2012). Biocompatibility and chemical reaction kinetics of injectable, 694 
settable polyurethane/allograft bone biocomposites. Acta Biomaterialia, 8(12), 4405–695 
4416. https://doi.org/10.1016/j.actbio.2012.07.037 696 
Park, W. S., Ahn, S. Y., Sung, S. I., Ahn, J. Y., & Chang, Y. S. (2018). Strategies to enhance 697 
paracrine potency of transplanted mesenchymal stem cells in intractable neonatal 698 
disorders. Pediatric Research, 83(1–2), 214–222. https://doi.org/10.1038/pr.2017.249 699 
Pérez-Limiñana, M. A., Arán-Aís, F., Torró-Palau, A. M., Orgilés-Barceló,  a. C., & Martín-700 
Martínez, J. M. (2005). Characterization of waterborne polyurethane adhesives 701 
containing different amounts of ionic groups. International Journal of Adhesion and 702 
Adhesives, 25(6), 507–517. https://doi.org/10.1016/j.ijadhadh.2005.02.002 703 
 
Pretsch, T., Jakob, I., & Müller, W. (2009). Hydrolytic degradation and functional stability of 704 
a segmented shape memory poly(ester urethane). Polymer Degradation and Stability, 705 
94(1), 61–73. https://doi.org/10.1016/j.polymdegradstab.2008.10.012 706 
Rowlands, a. S., Lim, S. a., Martin, D., & Cooper-White, J. J. (2007). Polyurethane/poly(lactic-707 
co-glycolic) acid composite scaffolds fabricated by thermally induced phase separation. 708 
Biomaterials, 28(12), 2109–2121. https://doi.org/10.1016/j.biomaterials.2006.12.032 709 
Sayed, O. N., Abdel-Rahman, R. M., Pavliňák, D., Abdel-Mohsen, A. M., Jancar, J., Burgert, 710 
L., … Fohlerova, Z. (2016). Wound dressing based on chitosan/hyaluronan/nonwoven 711 
fabrics: Preparation, characterization and medical applications. International Journal of 712 
Biological Macromolecules, 89, 725–736. https://doi.org/10.1016/j.ijbiomac.2016.04.087 713 
Subramani, S., Park, Y., Lee, Y., & Kim, J. (2003). New development of polyurethane 714 
dispersion derived from blocked aromatic diisocyanate. 48, 71–79. 715 
https://doi.org/10.1016/S0300-9440(03)00118-8 716 
Tao, Z., Shi, A., & Zhao, J. (2015). Epidemiological Perspectives of Diabetes. Cell 717 
Biochemistry and Biophysics, 73(1), 181–185. https://doi.org/10.1007/s12013-015-718 
0598-4 719 
Ünlü, C.H., Pollet, E., Avérous, L., Original Macromolecular Architectures Based on poly(ε-720 
caprolactone) and poly(ε-thiocaprolactone) Grafted onto Chitosan Backbone (2018) Int. 721 
J. Mol. Sci. 19, 3799. https://doi:10.3390/ijms19123799 722 
Velazquez-Morales, P., Le Nest, J.-F., & Gandini, A. (1998). Polymer electrolytes derived from 723 
chitosan/polyether networks. Electrochimica Acta, 43(10–11), 1275–1279. 724 
https://doi.org/10.1016/S0013-4686(97)10030-5 725 
Wang, W., Ping, P., Chen, X., & Jing, X. (2006). Polylactide-based polyurethane and its 726 
shape-memory behavior. European Polymer Journal, 42(6), 1240–1249. 727 
https://doi.org/10.1016/j.eurpolymj.2005.11.029 728 
Yamane, T., Nakagami, G., Yoshino, S., Shimura, M., Kitamura, A., Kobayashi-Hattori, K., … 729 
Sanada, H. (2015). Hydrocellular foam dressings promote wound healing associated 730 
with decrease in inflammation in rat periwound skin and granulation tissue, compared 731 
with hydrocolloid dressings. Bioscience, Biotechnology and Biochemistry, 79(2), 185–732 
189. https://doi.org/10.1080/09168451.2014.968088 733 
Zawadzki, J., & Kaczmarek, H. (2010). Thermal treatment of chitosan in various conditions. 734 
Carbohydrate Polymers, 80(2), 395–401. https://doi.org/10.1016/j.carbpol.2009.11.037 735 
Zhang, Shubiao, Cheng, L., & Hu, J. (2003). NMR studies of water-borne polyurethanes. 736 
Journal of Applied Polymer Science, 90(1), 257–260. https://doi.org/10.1002/app.12696 737 
Zhang, S., Ren, Z., He, S., Zhu, Y., & Zhu, C. (2007). FTIR spectroscopic characterization of 738 
polyurethane-urea model hard segments (PUUMHS) based on three diamine chain 739 
extenders. Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 740 
 
66(1), 188–193. https://doi.org/10.1016/j.saa.2006.02.041 741 
 742 
Zuber, M., Zia, K. M., Mahboob, S., Hassan, M., & Bhatti, I. A. (2010). Synthesis of chitin-743 
bentonite clay based polyurethane bio-nanocomposites. International Journal of 744 
Biological Macromolecules, 47(2), 196–200. 745 
https://doi.org/10.1016/j.ijbiomac.2010.04.022 746 
 747 
 748 
